Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Haematology
|
December 5, 2012
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients
Raija Silvennoinen, Veli Kairisto, Tarja-Terttu Pelliniemi, et al.
Plos One
|
December 6, 2018
Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
Kari Remes, Pekka Anttila, Raija Silvennoinen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation
Kate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Bone Marrow Transplantation
|
September 2, 2024
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients
Mats Brune, Thomas Kiss, Harald Anderson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 2, 2020
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide
Barbara Gamberi, Christian Berthou, Miguel Hernandez, et al.
Cytometry. Part B, Clinical Cytometry
|
June 10, 2010
Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma
Hans E Johnsen, Martin Bøgsted, Tobias W Klausen, et al.
European Journal of Haematology
|
August 2, 2014
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
Henrik Hjorth-Hansen, Leif Stenke, Stina Söderlund, et al.
European Journal of Haematology
|
September 18, 2021
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
Henrik Gregersen, Valdas Peceliunas, Kari Remes, et al.
Blood
|
April 26, 2013
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Ulf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, et al.
Blood
|
June 21, 2011
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
Bengt Simonsson, Tobias Gedde-Dahl, Berit Markevärn, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Haematology
|
December 5, 2012
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients
Raija Silvennoinen, Veli Kairisto, Tarja-Terttu Pelliniemi, et al.
Plos One
|
December 6, 2018
Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
Kari Remes, Pekka Anttila, Raija Silvennoinen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation
Kate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Bone Marrow Transplantation
|
September 2, 2024
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients
Mats Brune, Thomas Kiss, Harald Anderson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 2, 2020
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide
Barbara Gamberi, Christian Berthou, Miguel Hernandez, et al.
Cytometry. Part B, Clinical Cytometry
|
June 10, 2010
Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma
Hans E Johnsen, Martin Bøgsted, Tobias W Klausen, et al.
European Journal of Haematology
|
August 2, 2014
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
Henrik Hjorth-Hansen, Leif Stenke, Stina Söderlund, et al.
European Journal of Haematology
|
September 18, 2021
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
Henrik Gregersen, Valdas Peceliunas, Kari Remes, et al.
Blood
|
April 26, 2013
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Ulf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, et al.
Blood
|
June 21, 2011
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
Bengt Simonsson, Tobias Gedde-Dahl, Berit Markevärn, et al.
Page
of 4